Evidence map›Paper›PMID 30849388›Full record

ArticleMolecular cell2019

Large-Scale, Quantitative Protein Assays on a High-Throughput DNA Sequencing Chip.

Curtis J Layton, Peter L McMahon, William J Greenleaf

Abstract read
In one paragraph

Article in Molecular cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Amplicon/Protein Bead Display enables quantitativebioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. High-throughput discovery of inhibitory protein fragments with AlphaFold.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Review
  11. High-throughput discovery of inhibitory protein fragments with AlphaFold.bioRxiv : the preprint server for biology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Massively Parallel Profiling of RNA-targeting CRISPR-Cas13d.bioRxiv : the preprint server for biology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Curtis J LaytonDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA.
Peter L McMahonDepartment of Applied Physics, Stanford University, Stanford, CA 94305, USA.
William J GreenleafDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Applied Physics, Stanford University, Stanford, CA 94305, USA; Chan-Zuckerberg Initiative, Palo Alto, CA 94301, USA. Electronic address: wjg@stanford.edu.

Funding

Special EquipmentP50HG007735 · NHGRI · STANFORD UNIVERSITY · PI CHANG, HOWARD Y · 2014 to 2018
$15.2M
High-throughput systematic characterization of regulatory element functionUM1HG009436 · NHGRI · STANFORD UNIVERSITY · PI BASSIK, MICHAEL C, GREENLEAF, WILLIAM JAMES · 2017 to 2021
$5.4M
Quantitative high-throughput nucleic acid assays on a sequencing chipR01GM111990 · NIGMS · STANFORD UNIVERSITY · PI GREENLEAF, WILLIAM JAMES · 2014 to 2018
$1.5M
NHGRI NIH HHS P50 HG007735NHGRI NIH HHS UM1 HG009436NIGMS NIH HHS R01 GM111990
6 · The paper itself

Abstract

High-throughput DNA sequencing techniques have enabled diverse approaches for linking DNA sequence to biochemical function. In contrast, assays of protein function have substantial limitations in terms of throughput, automation, and widespread availability. We have adapted an Illumina high-throughput sequencing chip to display an immense diversity of ribosomally translated proteins and peptides and then carried out fluorescence-based functional assays directly on this flow cell, demonstrating that a single, widely available high-throughput platform can perform both sequencing-by-synthesis and protein assays. We quantified the binding of the M2 anti-FLAG antibody to a library of 1.3 × 10

Indexed as

AntibodiesAntibody AffinityAntibody SpecificityAutomation, LaboratoryBinding Sites, AntibodyCatalysisDNA Mutational AnalysisHigh-Throughput Nucleotide SequencingKineticsMutationO(6)-Methylguanine-DNA MethyltransferaseOligonucleotide Array Sequence AnalysisOligopeptidesProtein Array AnalysisProtein BindingProtein EngineeringAntibodiesFLAG peptideO(6)-Methylguanine-DNA MethyltransferaseOligopeptidesantibody characterizationhigh-throughputin vitro translationprotein arrayprotein engineeringprotein evolutionribosome displaysequencer hackingSNAP tagsuperFLAG

Identifiers

PMID30849388
PMCPMC7001660

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.